# Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes

> **NCT05221359** · NA · RECRUITING · sponsor: **Defymed** · enrollment: 8 (estimated)

## Conditions studied

- Type 1 Diabetes
- Type 1 Diabetes Mellitus With Hypoglycemia

## Interventions

- **DEVICE:** ExOlin®
- **DRUG:** Insulin aspart

## Key facts

- **NCT ID:** NCT05221359
- **Lead sponsor:** Defymed
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-05
- **Primary completion:** 2026-12
- **Final completion:** 2027-04
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2022-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05221359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05221359, "Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05221359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*